{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:51:29Z","timestamp":1788457889877,"version":"build-2803163510"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"S5","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["MMW - Fortschritte der Medizin"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s15006-017-9805-0","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T14:24:48Z","timestamp":1498141488000},"page":"22-33","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Mehr als ein Expektorans: neue wissenschaftliche Daten zu Ambroxol im Kontext der Behandlung bronchopulmonaler Erkrankungen","More than expectorant: new scientific data on ambroxol in the context of the treatment of bronchopulmonary diseases"],"prefix":"10.1007","volume":"159","author":[{"given":"Manuel","family":"Plomer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justus","family":"de Zeeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,22]]},"reference":[{"issue":"1\u20132","key":"9805_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-8741(00)00225-7","volume":"72","author":"U.P. Claeson","year":"2000","unstructured":"Claeson UP, et al. Adhatoda vasica: a critical review of ethnopharmacological and toxicological data. J Ethnopharmacol 2000; 72(1\u20132): 1\u201320.","journal-title":"J Ethnopharmacol"},{"key":"9805_CR2","first-page":"255","volume":"153","author":"B.G. Disse","year":"1987","unstructured":"Disse BG. The pharmacology of ambroxol \u2014 review and new results. Eur J Respir Dis Suppl 1987; 153: 255\u2013262.","journal-title":"Eur J Respir Dis Suppl"},{"issue":"11","key":"9805_CR3","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1517\/17460441.2011.629646","volume":"6","author":"D. Paleari","year":"2011","unstructured":"Paleari D, et al. Ambroxol: a multifaceted molecule with additional therapeutic potentials in respiratory disorders of childhood. Expert Opin Drug Discov 2011; 6(11): 1203\u20131214.","journal-title":"Expert Opin Drug Discov"},{"issue":"6","key":"9805_CR4","first-page":"363","volume":"26","author":"T. Castro de","year":"1988","unstructured":"de Castro T, de Cacanindin D. Clinical trial on ambroxol in acute and chronic bronchitis. Philipp J Intern Med 1988; 26(6): 363\u2013367.","journal-title":"Philipp J Intern Med"},{"issue":"Suppl1","key":"9805_CR5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000195273","volume":"51","author":"J. Germouty","year":"1987","unstructured":"Germouty J, Jirou-Najou JL. Clinical efficacy of ambroxol in the treatment of bronchial stasis. Clinical trial in 120 patients at two different doses. Respiration 1987; 51 Suppl 1: 37\u201341.","journal-title":"Respiration"},{"issue":"4","key":"9805_CR6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000193595","volume":"31","author":"J. Iravani","year":"1974","unstructured":"Iravani J, Melville GN. Mucociliary function of the respiratory tract as influenced by drugs. Respiration 1974; 31(4): 350\u2013357.","journal-title":"Respiration"},{"key":"9805_CR7","first-page":"361","volume-title":"Pulmonary Surfactant System","author":"C. Grassi","year":"1983","unstructured":"Grassi C, et al. Biomedical and functional changes in bronchoalveolar parameters induced by ambroxol treatment of chronic bronchitis. International Symposium Surfactant System of the Lung, Rome, 1983 March 2\u20134. In: Cosmi EV, Scarpelli EM (Hrsg). Pulmonary Surfactant System. Elsevier, Amsterdam 1983, S. 361\u2013370."},{"key":"9805_CR8","first-page":"145","volume":"153","author":"H. Dirksen","year":"1987","unstructured":"Dirksen H, et al. Mucociliary clearance in early simple chronic bronchitis. Eur J Respir Dis Suppl 1987; 153: 145\u2013149.","journal-title":"Eur J Respir Dis Suppl"},{"issue":"7","key":"9805_CR9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1055\/s-0032-1329684","volume":"30","author":"Z.Q. Zhang","year":"2013","unstructured":"Zhang ZQ, et al. Prevention of respiratory distress syndrome in preterm infants by antenatal ambroxol: a meta-analysis of randomized controlled trials. Am J Perinatol 2013; 30(7): 529\u2013536.","journal-title":"Am J Perinatol"},{"issue":"3","key":"9805_CR10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neulet.2005.10.058","volume":"395","author":"T. Weiser","year":"2006","unstructured":"Weiser T. Comparison of the effects of four Na+ channel analgesics on TTX-resistant Na+ currents in rat sensory neurons and recombinant Nav1.2 channels. Neurosci Lett 2006; 395(3): 179\u2013184.","journal-title":"Neurosci Lett"},{"issue":"3","key":"9805_CR11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1124\/mol.62.3.433","volume":"62","author":"T. Weiser","year":"2002","unstructured":"Weiser T, Wilson N. Inhibition of tetrodotoxin (TTX)-resistant and TTX-sensitive neuronal Na(+) channels by the secretolytic ambroxol. Mol Pharmacol 2002; 62(3): 433\u2013438.","journal-title":"Mol Pharmacol"},{"issue":"11","key":"9805_CR12","first-page":"557","volume":"58","author":"C. Mey de","year":"2008","unstructured":"de Mey C, et al. Efficacy and safety of ambroxol lozenges in the treatment of acute uncomplicated sore throat. EBM-based clinical documentation. Arzneimittelforschung 2008; 58(11): 557\u2013568.","journal-title":"Arzneimittelforschung"},{"issue":"12","key":"9805_CR13","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1055\/s-0035-1547229","volume":"65","author":"C. Mey de","year":"2015","unstructured":"de Mey C, et al. Efficacy and safety of an oral ambroxol spray in the treatment of acute uncomplicated sore throat. Drug Res (Stuttg) 2015; 65(12): 658\u2013667.","journal-title":"Drug Res (Stuttg)"},{"key":"9805_CR14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2296-15-45","volume":"15","author":"J.F. Chenot","year":"2014","unstructured":"Chenot JF, Weber P, Friede T. Efficacy of ambroxol lozenges for pharyngitis: a meta-analysis. BMC Fam Pract 2014; 15: 45.","journal-title":"BMC Fam Pract"},{"key":"9805_CR15","unstructured":"European Medicines Agency (EMA). Revised assessment report. Ambroxol and bromhexine containing medicinal products. EMA\/PRAC\/800767\/2015. Internet: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Ambroxol_and_bromhexine_31\/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee\/WC500184106.pdf (aufgerufen am 12.4.2016)."},{"key":"9805_CR16","unstructured":"European medicines Agency (EMA). European Commission final conclusion on the Ambroxol and bromhexine Article-31 referral \u2014 Annex II \u2014 Scientific conclusion. 2016 Internet: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Ambroxol_and_bromhexine_31\/European_Commission_final_decision\/WC500201290.pdf (aufgerufen am 12.4.2016)."},{"issue":"1","key":"9805_CR17","doi-asserted-by":"crossref","first-page":"e000137","DOI":"10.1136\/bmjresp-2016-000137","volume":"3","author":"A. Morice","year":"2016","unstructured":"Morice A, Kardos P. Comprehensive evidence-based review on European antitussives. BMJ Open Respir Res 2016; 3(1): e000137.","journal-title":"BMJ Open Respir Res"},{"key":"9805_CR18","first-page":"CD001287","volume":"7","author":"P. Poole","year":"2015","unstructured":"Poole P, Chong J, Cates CJ. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2015; 7: CD001287.","journal-title":"Cochrane Database Syst Rev"},{"key":"9805_CR19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000195274","volume":"51Suppl1","author":"D. Olivieri","year":"1987","unstructured":"Olivieri D, et al. Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo. Respiration 1987; 51 Suppl 1: 42\u201351.","journal-title":"Respiration"},{"issue":"9","key":"9805_CR20","first-page":"715","volume":"42","author":"U.H. Cegla","year":"1988","unstructured":"Cegla UH. Long-term therapy over 2 years with ambroxol (Mucosolvan) retard capsules in patients with chronic bronchitis. Results of a double-blind study of 180 patients. Prax Klin Pneumol 1988; 42(9): 715\u2013721.","journal-title":"Prax Klin Pneumol"},{"issue":"1","key":"9805_CR21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pupt.2003.08.004","volume":"17","author":"M. Malerba","year":"2004","unstructured":"Malerba M, et al. Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial). Pulm Pharmacol Ther 2004; 17(1): 27\u201334.","journal-title":"Pulm Pharmacol Ther"},{"issue":"4","key":"9805_CR22","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1378\/chest.92.4.618","volume":"92","author":"G.H. Guyatt","year":"1987","unstructured":"Guyatt GH, et al. A controlled trial of ambroxol in chronic bronchitis. Chest 1987; 92(4): 618\u2013620.","journal-title":"Chest"},{"issue":"8","key":"9805_CR23","first-page":"700","volume":"50","author":"H. Matthys","year":"2000","unstructured":"Matthys H, et al. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol. Arzneimittelforschung 2000; 50(8): 700\u2013711.","journal-title":"Arzneimittelforschung"},{"key":"9805_CR24","unstructured":"Arzneimittelkommission der deutschen \u00c4rzteschaft (AKd\u00c4). Handlungsleitlinie Atemwegsinfektionen aus Empfehlungen zur Therapie akuter Atemwegsinfektionen und der ambulant erworbenen Pneumonie (3. Auflage). 2013 Internet: http:\/\/www.akdae.de\/Arzneimitteltherapie\/TE\/A-Z\/PDF_Kurzversion\/Atemwegsinfektionen_k.pdf (aufgerufen am 18.5.2016)."},{"issue":"4","key":"9805_CR25","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1177\/039463200902200407","volume":"22","author":"B.F. Gibbs","year":"2009","unstructured":"Gibbs BF. Differential modulation of IgE-dependent activation of human basophils by ambroxol and related secretolytic analogues. Int J Immunopathol Pharmacol 2009; 22(4): 919\u2013927.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"9805_CR26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.resp.2011.12.008","volume":"181","author":"C. Dong","year":"2012","unstructured":"Dong C, et al. Anti-asthmatic agents alleviate pulmonary edema by upregulating AQP1 and AQP5 expression in the lungs of mice with OVA-induced asthma. Respir Physiol Neurobiol 2012; 181(1): 21\u201328.","journal-title":"Respir Physiol Neurobiol"},{"issue":"18","key":"9805_CR27","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2169\/internalmedicine.50.5407","volume":"50","author":"Q.M. Zhi","year":"2011","unstructured":"Zhi QM, Yang LT, Sun HC. Protective effect of ambroxol against paraquat-induced pulmonary fibrosis in rats. Intern Med 2011; 50(18): 1879\u20131887.","journal-title":"Intern Med"},{"issue":"3","key":"9805_CR28","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s11655-013-1619-z","volume":"20","author":"Y. Wang","year":"2014","unstructured":"Wang Y, et al. Effects of Fengbaisan on the expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung tissue of rats with chronic obstructive pulmonary disease. Chin J Integr Med 2014; 20(3): 224\u2013231.","journal-title":"Chin J Integr Med"},{"key":"9805_CR29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2147\/COPD.S10981","volume":"5","author":"M. Yakoot","year":"2010","unstructured":"Yakoot M, Salem A, Omar AM. Clinical efficacy of farcosolvin syrup (ambroxol-theophylline-guaiphenesin mixture) in the treatment of acute exacerbation of chronic bronchitis. Int J Chron Obstruct Pulmon Dis 2010; 5: 251\u2013256.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"9805_CR30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.33145\/2304-8336-2015-20-457-466","volume":"20","author":"V.O. Sushko","year":"2015","unstructured":"Sushko VO, et al. Optimization of chronic obstructive pulmonary disease treatment in clean-up workers of the Chornobyl NPP accident in the remote period after irradiation. Probl Radiac Med Radiobiol 2015; 20: 457\u2013466.","journal-title":"Probl Radiac Med Radiobiol"},{"key":"9805_CR31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13256-015-0588-6","volume":"9","author":"N. Oda","year":"2015","unstructured":"Oda N, et al. Marked improvement in autoimmune pulmonary alveolar proteinosis with severe hypoxemia in a patient treated with ambroxol: a case report. J Med Case Rep 2015; 9: 100.","journal-title":"J Med Case Rep"},{"issue":"2","key":"9805_CR32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10238-006-0099-2","volume":"6","author":"K. Nobata","year":"2006","unstructured":"Nobata K, et al. Ambroxol for the prevention of acute upper respiratory disease. Clin Exp Med 2006; 6(2): 79\u201383.","journal-title":"Clin Exp Med"},{"issue":"9","key":"9805_CR33","doi-asserted-by":"crossref","first-page":"409","DOI":"10.5414\/CPP44409","volume":"44","author":"M. Schulz","year":"2006","unstructured":"Schulz M, et al. Safety and usage pattern of an over-the-counter ambroxol cough syrup: a community pharmacy-based cohort study. Int J Clin Pharmacol Ther 2006; 44(9): 409\u2013421.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"11","key":"9805_CR34","first-page":"842","volume":"69","author":"Y. Zhou","year":"2014","unstructured":"Zhou Y, et al. Efficacy and safety of letosteine in the treatment of sputum thickening and expectoration difficulty in patients with respiratory diseases: a multicenter, randomized, double-masked, double dummy, positive drug parallel controlled trial. Pharmazie 2014; 69(11): 842\u2013849.","journal-title":"Pharmazie"},{"issue":"4Suppl","key":"9805_CR35","first-page":"1477","volume":"28","author":"F. Yang","year":"2015","unstructured":"Yang F. Oxygen-driving and atomized mucosolvan inhalation combined with holistic nursing in the treatment of children severe bronchial pneumonia. Pak J Pharm Sci 2015; 28(4 Suppl): 1477\u20131480.","journal-title":"Pak J Pharm Sci"},{"issue":"5418","key":"9805_CR36","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","volume":"284","author":"J.W. Costerton","year":"1999","unstructured":"Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284(5418): 1318\u20131322.","journal-title":"Science"},{"issue":"3","key":"9805_CR37","first-page":"168","volume":"7","author":"R.B. Fick Jr","year":"1992","unstructured":"Fick RB Jr, Sonoda F, Hornick DB. Emergence and persistence of Pseudomonas aeruginosa in the cystic fibrosis airway. Semin Respir Infect 1992; 7(3): 168\u2013178.","journal-title":"Semin Respir Infect"},{"issue":"1","key":"9805_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00284-008-9142-8","volume":"57","author":"F. Li","year":"2008","unstructured":"Li F, et al. Effects of ambroxol on alginate of mature Pseudomonas aeruginosa biofilms. Curr Microbiol 2008; 57(1): 1\u20137.","journal-title":"Curr Microbiol"},{"issue":"3","key":"9805_CR39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijantimicag.2010.05.007","volume":"36","author":"Q. Lu","year":"2010","unstructured":"Lu Q, et al. Ambroxol interferes with Pseudomonas aeruginosa quorum sensing. Int J Antimicrob Agents 2010; 36(3): 211\u2013215.","journal-title":"Int J Antimicrob Agents"},{"key":"9805_CR40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejps.2015.01.005","volume":"70","author":"S.H. Lee","year":"2015","unstructured":"Lee SH, et al. A novel inhaled multi-pronged attack against respiratory bacteria. Eur J Pharm Sci 2015; 70: 37\u201344.","journal-title":"Eur J Pharm Sci"},{"issue":"12","key":"9805_CR41","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.prp.2015.10.003","volume":"211","author":"C. Cheng","year":"2015","unstructured":"Cheng C, et al. Ciprofloxacin plus erythromycin or ambroxol ameliorates endotracheal tube-associated Pseudomonas aeruginosa biofilms in a rat model. Pathol Res Pract 2015; 211(12): 982\u2013988.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"9805_CR42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000351107","volume":"59","author":"Q. Lu","year":"2013","unstructured":"Lu Q, et al. Effects of combined treatment with ambroxol and ciprofloxacin on catheter-associated Pseudomonas aeruginosa biofilms in a rat model. Chemotherapy 2013; 59(1): 51\u201356.","journal-title":"Chemotherapy"},{"issue":"2","key":"9805_CR43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000323622","volume":"57","author":"F. Li","year":"2011","unstructured":"Li F, et al. Effect of ambroxol on pneumonia caused by Pseudomonas aeruginosa with biofilm formation in an endotracheal intubation rat model. Chemotherapy 2011; 57(2): 173\u2013180.","journal-title":"Chemotherapy"},{"issue":"11","key":"9805_CR44","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jiac.2015.08.017","volume":"21","author":"Y. Zhang","year":"2015","unstructured":"Zhang Y, et al. Synergy of ambroxol with vancomycin in elimination of catheter-related Staphylococcus epidermidis biofilm in vitro and in vivo. J Infect Chemother 2015; 21(11): 808\u2013815.","journal-title":"J Infect Chemother"},{"issue":"2","key":"9805_CR45","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3892\/etm.2014.2112","volume":"9","author":"F. Chen","year":"2015","unstructured":"Chen F, Zhang YX, Zhang CQ. Effect of ambroxol on the concentration of cefotaxime in the bronchoalveolar lavage fluid of rats with pulmonary fibrosis. Exp Ther Med 2015; 9(2): 539\u2013542.","journal-title":"Exp Ther Med"},{"issue":"1","key":"9805_CR46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12010-008-8312-2","volume":"158","author":"M.M. Hafez","year":"2009","unstructured":"Hafez MM, et al. Activity of some mucolytics against bacterial adherence to mammalian cells. Appl Biochem Biotechnol 2009; 158(1): 97\u2013112.","journal-title":"Appl Biochem Biotechnol"},{"issue":"4","key":"9805_CR47","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1567-1364.2012.00792.x","volume":"12","author":"G. Pulcrano","year":"2012","unstructured":"Pulcrano G, et al. Ambroxol influences voriconazole resistance of Candida parapsilosis biofilm. FEMS Yeast Res 2012; 12(4): 430\u2013438.","journal-title":"FEMS Yeast Res"},{"issue":"4","key":"9805_CR48","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/myc.12147","volume":"57","author":"H.D. Rene","year":"2014","unstructured":"Rene HD, et al. Effects of ambroxol on Candida albicans growth and biofilm formation. Mycoses 2014; 57(4): 228\u2013232.","journal-title":"Mycoses"},{"issue":"4","key":"9805_CR49","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s12272-013-0210-7","volume":"37","author":"M. Yamaya","year":"2014","unstructured":"Yamaya M, et al. Ambroxol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells. Arch Pharm Res 2014; 37(4): 520\u2013529.","journal-title":"Arch Pharm Res"},{"key":"9805_CR50","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.biochi.2013.09.024","volume":"97","author":"J. Huang","year":"2014","unstructured":"Huang J, et al. A thioredoxin reductase and\/or thioredoxin system-based mechanism for antioxidant effects of ambroxol. Biochimie 2014; 97: 92\u2013103.","journal-title":"Biochimie"},{"issue":"4","key":"9805_CR51","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1177\/039463201302600406","volume":"26","author":"D.G. Peroni","year":"2013","unstructured":"Peroni DG, et al. Ambroxol inhibits neutrophil respiratory burst activated by alpha chain integrin adhesion. Int J Immunopathol Pharmacol 2013; 26(4): 883\u2013887.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"6","key":"9805_CR52","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1159\/000381905","volume":"89","author":"F.L. Ricciardolo","year":"2015","unstructured":"Ricciardolo FL, et al. Effect of ambroxol and beclomethasone on lipopolysaccharide-induced nitrosative stress in bronchial epithelial cells. Respiration 2015; 89(6): 572\u2013582.","journal-title":"Respiration"},{"issue":"3","key":"9805_CR53","doi-asserted-by":"crossref","first-page":"405","DOI":"10.5114\/aoms.2011.23403","volume":"7","author":"X. Gao","year":"2011","unstructured":"Gao X, et al. The protective effects of ambroxol in Pseudomonas aeruginosa-induced pneumonia in rats. Arch Med Sci 2011; 7(3): 405\u2013413.","journal-title":"Arch Med Sci"},{"issue":"1","key":"9805_CR54","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.etap.2014.04.030","volume":"38","author":"Y. Chen","year":"2014","unstructured":"Chen Y, et al. Mucoactive effects of naringin in lipopolysaccharide-induced acute lung injury mice and beagle dogs. Environ Toxicol Pharmacol 2014; 38(1): 279\u2013287.","journal-title":"Environ Toxicol Pharmacol"},{"issue":"1","key":"9805_CR55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.gene.2015.11.024","volume":"577","author":"X. Su","year":"2016","unstructured":"Su X, et al. The protective effect of different airway humidification liquids to lung after tracheotomy in traumatic brain injury: The role of pulmonary surfactant protein-A (SP-A). Gene 2016; 577(1): 89\u201395.","journal-title":"Gene"},{"issue":"6","key":"9805_CR56","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/FJC.0b013e31819036c7","volume":"52","author":"M.M. Ulas","year":"2008","unstructured":"Ulas MM, et al. Protective effect of ambroxol on pulmonary function after cardiopulmonary bypass. J Cardiovasc Pharmacol 2008; 52(6): 518\u2013523.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"9805_CR57","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ejcts.2008.11.015","volume":"35","author":"M. Refai","year":"2009","unstructured":"Refai M, et al. Short-term perioperative treatment with ambroxol reduces pulmonary complications and hospital costs after pulmonary lobectomy: a randomized trial. Eur J Cardiothorac Surg 2009; 35(3): 469\u2013473.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"9805_CR58","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12013-015-0590-z","volume":"73","author":"X. Wang","year":"2015","unstructured":"Wang X, et al. Perioperative lung protection provided by high-dose ambroxol in patients with lung cancer. Cell Biochem Biophys 2015; 73(2): 281\u2013284.","journal-title":"Cell Biochem Biophys"},{"issue":"3","key":"9805_CR59","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s12032-009-9271-3","volume":"27","author":"D.H. Xia","year":"2010","unstructured":"Xia DH, et al. The protective effects of ambroxol on radiation lung injury and influence on production of transforming growth factor beta1 and tumor necrosis factor alpha. Med Oncol 2010; 27(3): 697\u2013701.","journal-title":"Med Oncol"},{"issue":"4","key":"9805_CR60","first-page":"587","volume":"52","author":"H. Dreger","year":"2011","unstructured":"Dreger H, et al. Fast-track pulmonary conditioning before urgent cardiac surgery in patients with insufficiently treated chronic obstructive pulmonary disease. J Cardiovasc Surg (Torino) 2011; 52(4): 587\u2013591.","journal-title":"J Cardiovasc Surg (Torino)"},{"issue":"2","key":"9805_CR61","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12028-011-9642-4","volume":"16","author":"Q. Li","year":"2012","unstructured":"Li Q, Yao G, Zhu X. High-dose ambroxol reduces pulmonary complications in patients with acute cervical spinal cord injury after surgery. Neurocrit Care 2012; 16(2): 267\u2013272.","journal-title":"Neurocrit Care"},{"issue":"5","key":"9805_CR62","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/tropej\/fmv033","volume":"61","author":"A.K. Baranwal","year":"2015","unstructured":"Baranwal AK, Murthy AS, Singhi SC. High-dose oral ambroxol for early treatment of pulmonary acute respiratory distress syndrome: an exploratory, randomized, controlled pilot trial. J Trop Pediatr 2015; 61(5): 339\u2013350.","journal-title":"J Trop Pediatr"},{"issue":"11","key":"9805_CR63","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/jcph.389","volume":"54","author":"X. Wu","year":"2014","unstructured":"Wu X, et al. Meta-analysis of high doses of ambroxol treatment for acute lung injury\/acute respiratory distress syndrome based on randomized controlled trials. J Clin Pharmacol 2014; 54(11): 1199\u20131206.","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"9805_CR64","first-page":"63","volume":"6","author":"X.Q. Chen","year":"2012","unstructured":"Chen XQ, et al. Effects of antenatal application of ambroxol and glucocorticoid on lung morphometry and signal transduction of bone morphogenetic protein in the fetal rat. Mol Med Rep 2012; 6(1): 63\u201368.","journal-title":"Mol Med Rep"},{"issue":"2","key":"9805_CR65","doi-asserted-by":"crossref","first-page":"41","DOI":"10.18295\/2075-0528.2625","volume":"6","author":"H.F. Elsayed","year":"2006","unstructured":"Elsayed HF, et al. Evaluation of the role of postnatal ambroxol in the prevention and treatment of respiratory distress syndrome in preterm neonates. Sultan Qaboos Univ Med J 2006; 6(2): 41\u201346.","journal-title":"Sultan Qaboos Univ Med J"},{"issue":"6","key":"9805_CR66","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ceca.2015.10.002","volume":"58","author":"G. Fois","year":"2015","unstructured":"Fois G, et al. A new role for an old drug: Ambroxol triggers lysosomal exocytosis via pH-dependent Ca(2)(+) release from acidic Ca(2)(+) stores. Cell Calcium 2015; 58(6): 628\u2013637.","journal-title":"Cell Calcium"},{"issue":"2","key":"9805_CR67","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.bbrc.2006.03.009","volume":"343","author":"I. Hasegawa","year":"2006","unstructured":"Hasegawa I, et al. Ambroxol-induced modification of ion transport in human airway Calu-3 epithelia. Biochem Biophys Res Commun 2006; 343(2): 475\u2013482.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"9805_CR68","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/01902148.2014.934411","volume":"41","author":"S. Hussain","year":"2015","unstructured":"Hussain S, et al. N-acetylcysteine and azithromycin affect the innate immune response in cystic fibrosis bronchial epithelial cells in vitro. Exp Lung Res 2015; 41(5): 251\u2013260.","journal-title":"Exp Lung Res"},{"issue":"11","key":"9805_CR69","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/cbin.10146","volume":"37","author":"G. Varelogianni","year":"2013","unstructured":"Varelogianni G, et al. The effect of ambroxol on chloride transport, CFTR and ENaC in cystic fibrosis airway epithelial cells. Cell Biol Int 2013; 37(11): 1149\u20131156.","journal-title":"Cell Biol Int"},{"key":"9805_CR70","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1465-9921-13-98","volume":"13","author":"J. Seagrave","year":"2012","unstructured":"Seagrave J, et al. Effects of guaifenesin, N-acetylcysteine, and ambroxol on MUC5AC and mucociliary transport in primary differentiated human tracheal-bronchial cells. Respir Res 2012; 13: 98.","journal-title":"Respir Res"},{"issue":"1-3","key":"9805_CR71","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejphar.2010.11.019","volume":"652","author":"J. Kamei","year":"2011","unstructured":"Kamei J, et al. Possible involvement of tetrodotoxin-resistant sodium channels in cough reflex. Eur J Pharmacol 2011; 652(1-3): 117\u2013120.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"9805_CR72","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/jnr.22754","volume":"90","author":"P. Rohnert","year":"2012","unstructured":"Rohnert P, et al. Insufficient endogenous redox buffer capacity may underlie neuronal vulnerability to cerebral ischemia and reperfusion. J Neurosci Res 2012; 90(1): 193\u2013202.","journal-title":"J Neurosci Res"},{"issue":"6","key":"9805_CR73","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.transproceed.2013.04.007","volume":"45","author":"K. Jiang","year":"2013","unstructured":"Jiang K, et al. Ambroxol alleviates hepatic ischemia reperfusion injury by antioxidant and antiapoptotic pathways. Transplant Proc 2013; 45(6): 2439\u20132445.","journal-title":"Transplant Proc"},{"issue":"3PtA","key":"9805_CR74","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ejpb.2013.03.020","volume":"85","author":"F. Tewes","year":"2013","unstructured":"Tewes F, et al. Steroid\/mucokinetic hybrid nanoporous microparticles for pulmonary drug delivery. Eur J Pharm Biopharm 2013; 85(3 Pt A): 604\u2013613.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"9805_CR75","first-page":"137","volume":"31","author":"J.A. Wiktorska","year":"2010","unstructured":"Wiktorska JA, et al. Effects of certain antioxidants on lipid peroxidation process in lung homogenates of L thyroxine-receiving rats. Neuro Endocrinol Lett 2010; 31(1): 137\u2013146.","journal-title":"Neuro Endocrinol Lett"},{"issue":"7","key":"9805_CR76","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/ICO.0b013e318285c8d3","volume":"32","author":"D. Kim","year":"2013","unstructured":"Kim D, et al. Effects of oral mucolytics on tear film and ocular surface. Cornea 2013; 32(7): 933\u2013938.","journal-title":"Cornea"},{"issue":"3","key":"9805_CR77","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/WNF.0000000000000031","volume":"37","author":"L. Lapenta","year":"2014","unstructured":"Lapenta L, et al. Ambroxol-induced focal epileptic seizure. Clin Neuropharmacol 2014; 37(3): 84\u201387.","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"9805_CR78","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/039463201202500123","volume":"25","author":"A. Macchi","year":"2012","unstructured":"Macchi A, Terranova P, Castelnuovo P. Recurrent acute rhinosinusitis: a single blind clinical study of N-acetylcysteine vs ambroxol associated to corticosteroid therapy. Int J Immunopathol Pharmacol 2012; 25(1): 207\u2013217.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"35","key":"9805_CR79","doi-asserted-by":"crossref","first-page":"23502","DOI":"10.1074\/jbc.M109.012393","volume":"284","author":"G.H. Maegawa","year":"2009","unstructured":"Maegawa GH, et al. Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease. J Biol Chem 2009; 284(35): 23502\u201323516.","journal-title":"J Biol Chem"},{"issue":"1","key":"9805_CR80","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bcmd.2010.10.012","volume":"46","author":"I. Bendikov-Bar","year":"2011","unstructured":"Bendikov-Bar I, et al. Characterization of the ERAD process of the L444P mutant glucocerebrosidase variant. Blood Cells Mol Dis 2011; 46(1): 4\u201310.","journal-title":"Blood Cells Mol Dis"},{"key":"9805_CR81","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.nbd.2015.06.008","volume":"82","author":"G. Ambrosi","year":"2015","unstructured":"Ambrosi G, et al. Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells. Neurobiol Dis 2015; 82: 235\u2013242.","journal-title":"Neurobiol Dis"},{"issue":"3","key":"9805_CR82","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/mt.2014.224","volume":"23","author":"J. Lukas","year":"2015","unstructured":"Lukas J, et al. Enzyme enhancers for the treatment of Fabry and Pompe disease. Mol Ther 2015; 23(3): 456\u2013464.","journal-title":"Mol Ther"},{"issue":"3","key":"9805_CR83","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ymgme.2012.04.018","volume":"106","author":"G. Babajani","year":"2012","unstructured":"Babajani G, et al. Pharmacological chaperones facilitate the post-ER transport of recombinant N370S mutant beta-glucocerebrosidase in plant cells: evidence that N370S is a folding mutant. Mol Genet Metab 2012; 106(3): 323\u2013329.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"9805_CR84","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bcmd.2012.10.007","volume":"50","author":"I. Bendikov-Bar","year":"2013","unstructured":"Bendikov-Bar I, et al. Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase. Blood Cells Mol Dis 2013; 50(2): 141\u2013145.","journal-title":"Blood Cells Mol Dis"},{"issue":"8","key":"9805_CR85","doi-asserted-by":"crossref","first-page":"e69147","DOI":"10.1371\/journal.pone.0069147","volume":"8","author":"T. Suzuki","year":"2013","unstructured":"Suzuki T, et al. Expression of human Gaucher disease gene GBA generates neurodevelopmental defects and ER stress in Drosophila eye. PLoS One 2013; 8(8): e69147.","journal-title":"PLoS One"},{"issue":"Pt5","key":"9805_CR86","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awu020","volume":"137","author":"A. McNeill","year":"2014","unstructured":"McNeill A, et al. Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells. Brain 2014; 137(Pt 5): 1481\u20131495.","journal-title":"Brain"},{"issue":"9","key":"9805_CR87","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/stem.1732","volume":"32","author":"L.M. Panicker","year":"2014","unstructured":"Panicker LM, et al. Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development. Stem Cells 2014; 32(9): 2338\u20132349.","journal-title":"Stem Cells"},{"key":"9805_CR88","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1002\/ajh.24055","volume":"90Suppl1","author":"P.K. Mistry","year":"2015","unstructured":"Mistry PK, et al. Understanding the natural history of Gaucher disease. Am J Hematol 2015; 90 Suppl 1: S6\u201311.","journal-title":"Am J Hematol"},{"issue":"4","key":"9805_CR89","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.braindev.2012.05.008","volume":"35","author":"Z. Luan","year":"2013","unstructured":"Luan Z, et al. The chaperone activity and toxicity of ambroxol on Gaucher cells and normal mice. Brain Dev 2013; 35(4): 317\u2013322.","journal-title":"Brain Dev"},{"issue":"2","key":"9805_CR90","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bcmd.2012.09.006","volume":"50","author":"A. Zimran","year":"2013","unstructured":"Zimran A, Altarescu G, Elstein D. Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease. Blood Cells Mol Dis 2013; 50(2): 134\u2013137.","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"9805_CR91","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","volume":"187","author":"J. Vestbo","year":"2013","unstructured":"Vestbo J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187(4): 347\u2013365.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"9805_CR92","first-page":"734","volume":"43","author":"F. Fraschini","year":"1988","unstructured":"Fraschini F, et al. Effects of a mucolytic agent on the bioavailability of antibiotics in patients with chronic respiratory diseases. Curr Ther Res 1988; 43(4): 734\u2013742.","journal-title":"Curr Ther Res"},{"issue":"8","key":"9805_CR93","first-page":"967","volume":"37","author":"R. Gene","year":"1987","unstructured":"Gene R, et al. Influence of ambroxol on amoxicillin levels in bronchoalveolar lavage fluid. Arzneimittelforschung 1987; 37(8): 967\u2013968.","journal-title":"Arzneimittelforschung"},{"key":"9805_CR94","first-page":"5","volume":"12","author":"J. Perez-Neria","year":"1992","unstructured":"Perez-Neria J, Garcia Rubi E. Ambroxol-amoxiciline fixed combination vs. amoxiciline in acute infectious respiratory conditions \u2014 Comparative study of antibiotic levels in bronchial mucus and blood. Compend Invest Clin Lat Am 1992; 12: 5\u201310.","journal-title":"Compend Invest Clin Lat Am"}],"container-title":["MMW - Fortschritte der Medizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-017-9805-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T22:56:30Z","timestamp":1750373790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.springermedizin.de\/doi\/10.1007\/s15006-017-9805-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":94,"journal-issue":{"issue":"S5","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["9805"],"URL":"https:\/\/doi.org\/10.1007\/s15006-017-9805-0","relation":{},"ISSN":["1438-3276","1613-3560"],"issn-type":[{"value":"1438-3276","type":"print"},{"value":"1613-3560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}